Chronic Heart Failure Drug Sales Expected to Increase
New forecasts published by Decision Resources show an expected increase in the sales of medicines to treat chronic heart failure. The forecasts show growth from around $2.9 billion in 2013 to an expected $8.9 billion in 2023. Growth in seven main markets (US, UK, France, Germany, Italy, Spain and Japan) will be driven mainly by